MICHAEL WHITE to Carcinoma, Pancreatic Ductal
This is a "connection" page, showing publications MICHAEL WHITE has written about Carcinoma, Pancreatic Ductal.
Connection Strength
1.453
-
ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4623-4624.
Score: 0.625
-
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4615-4622.
Score: 0.622
-
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015 Apr 09; 6:6744.
Score: 0.104
-
MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep. 2014 Dec 24; 9(6):2233-49.
Score: 0.102